[vc_row][vc_column offset=”vc_col-lg-offset-1 vc_col-lg-10″][vc_column_text]
Publications
[/vc_column_text][/vc_column][/vc_row]
-
May 21, 2024
Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumors
-
January 15, 2024
First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors